BioCentury | Dec 22, 2014
Clinical News

ATX-F8-117 regulatory update

...The European Commission granted Orphan Drug designation to ATX-F8-117 from Apitope to treat hemophilia A. The...
...Factor VIII inhibitor formation in hemophilia A patients. Apitope International N.V. , Diepenbeek, Belgium Product: ATX-F8-117...
Items per page:
1 - 1 of 1